BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 27186904)

  • 21. Reverse Screening Methods to Search for the Protein Targets of Chemopreventive Compounds.
    Huang H; Zhang G; Zhou Y; Lin C; Chen S; Lin Y; Mai S; Huang Z
    Front Chem; 2018; 6():138. PubMed ID: 29868550
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ProSelection: A Novel Algorithm to Select Proper Protein Structure Subsets for in Silico Target Identification and Drug Discovery Research.
    Wang N; Wang L; Xie XQ
    J Chem Inf Model; 2017 Nov; 57(11):2686-2698. PubMed ID: 29016123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NMR-Assisted Molecular Docking Methodologies.
    Sturlese M; Bellanda M; Moro S
    Mol Inform; 2015 Aug; 34(8):513-25. PubMed ID: 27490497
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tools for in silico target fishing.
    Cereto-Massagué A; Ojeda MJ; Valls C; Mulero M; Pujadas G; Garcia-Vallve S
    Methods; 2015 Jan; 71():98-103. PubMed ID: 25277948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Recent Advances in In Silico Target Fishing.
    Galati S; Di Stefano M; Martinelli E; Poli G; Tuccinardi T
    Molecules; 2021 Aug; 26(17):. PubMed ID: 34500568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exploring Polypharmacology in Drug Design.
    Saenz-Méndez P; Eriksson LA
    Methods Mol Biol; 2018; 1824():229-243. PubMed ID: 30039410
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The latest automated docking technologies for novel drug discovery.
    Caballero J
    Expert Opin Drug Discov; 2021 Jun; 16(6):625-645. PubMed ID: 33353444
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The compromise of virtual screening and its impact on drug discovery.
    Slater O; Kontoyianni M
    Expert Opin Drug Discov; 2019 Jul; 14(7):619-637. PubMed ID: 31025886
    [No Abstract]   [Full Text] [Related]  

  • 29. MDock: A Suite for Molecular Inverse Docking and Target Prediction.
    Ma Z; Zou X
    Methods Mol Biol; 2021; 2266():313-322. PubMed ID: 33759135
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Yada: a novel tool for molecular docking calculations.
    Piotto S; Di Biasi L; Fino R; Parisi R; Sessa L; Concilio S
    J Comput Aided Mol Des; 2016 Sep; 30(9):753-759. PubMed ID: 27565794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hot-spot analysis for drug discovery targeting protein-protein interactions.
    Rosell M; Fernández-Recio J
    Expert Opin Drug Discov; 2018 Apr; 13(4):327-338. PubMed ID: 29376444
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Essential considerations for using protein-ligand structures in drug discovery.
    Warren GL; Do TD; Kelley BP; Nicholls A; Warren SD
    Drug Discov Today; 2012 Dec; 17(23-24):1270-81. PubMed ID: 22728777
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of drug candidates and repurposing opportunities through compound-target interaction networks.
    Cichonska A; Rousu J; Aittokallio T
    Expert Opin Drug Discov; 2015 Dec; 10(12):1333-45. PubMed ID: 26429153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macromolecular Modelling and Docking Simulations for the Discovery of Selective GPER Ligands.
    Rosano C; Ponassi M; Santolla MF; Pisano A; Felli L; Vivacqua A; Maggiolini M; Lappano R
    AAPS J; 2016 Jan; 18(1):41-6. PubMed ID: 26573009
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Getting the most out of PubChem for virtual screening.
    Kim S
    Expert Opin Drug Discov; 2016 Sep; 11(9):843-55. PubMed ID: 27454129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Macromolecular target prediction by self-organizing feature maps.
    Schneider G; Schneider P
    Expert Opin Drug Discov; 2017 Mar; 12(3):271-277. PubMed ID: 27997811
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Promiscuity in drug discovery on the verge of the structural revolution: recent advances and future chances.
    Bolz SN; Schroeder M
    Expert Opin Drug Discov; 2023; 18(9):973-985. PubMed ID: 37489516
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Protein-ligand-based pharmacophores: generation and utility assessment in computational ligand profiling.
    Meslamani J; Li J; Sutter J; Stevens A; Bertrand HO; Rognan D
    J Chem Inf Model; 2012 Apr; 52(4):943-55. PubMed ID: 22480372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The development of novel polypharmacological agents targeting the multiple binding sites of nicotinic acetylcholine receptors.
    Reyes-Parada M; Iturriaga-Vasquez P
    Expert Opin Drug Discov; 2016 Oct; 11(10):969-81. PubMed ID: 27552487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incorporating backbone flexibility in MedusaDock improves ligand-binding pose prediction in the CSAR2011 docking benchmark.
    Ding F; Dokholyan NV
    J Chem Inf Model; 2013 Aug; 53(8):1871-9. PubMed ID: 23237273
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.